Biochemical characterization of TEM-92 extended-spectrum β-lactamase, a protein differing from TEM-52 in the signal peptide

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3981-3983

  Perilli, Mariagrazia ^a   Segatore, Bernardetta ^a   De Massis, Maria Rosaria ^a   Pagani, Laura ^b   Luzzaro, Francesco ^c   Rossolini, Gian Maria ^d   Amicosante, Gianfranco ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c OSPEDALE DI CIRCOLO   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BETA LACTAMASE TEM92; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN; CEPHAMYCIN DERIVATIVE; CLAVULANIC ACID; LATAMOXEF; LORACARBEF; NITROCEFIN; PENICILLANIC ACID; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULFONE DERIVATIVE; TAZOBACTAM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE TEM 92; BETA-LACTAMASE TEM-92; TEM 52 BETA LACTAMASE; TEM-52 BETA-LACTAMASE;

ACYLATION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BINDING KINETICS; BIOCHEMISTRY; BLA TEM92 GENE; DEACYLATION; DRUG SPECIFICITY; ENZYME PURIFICATION; ENZYME RELEASE; ENZYME STRUCTURE; ESCHERICHIA COLI; GENE IDENTIFICATION; HYDROLYSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PENICILLIN RESISTANCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEUS MIRABILIS; REACTION OPTIMIZATION; REDUCTION; ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; KINETICS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CEPHALOSPORIN RESISTANCE; ESCHERICHIA COLI; KINETICS; PENICILLIN RESISTANCE;

EID: 0036896966     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3981-3983.2002     Document Type: Article

References (16)

1. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
2. Chanal, C., D. Sirot, J. P. Romaszko, L. Bret, and J. Sirot. 1996. Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae. J. Antimicrob. Chemother. 38:127-132.
3. De Champs, C., C. Monne, R. Bonnet, W. Sougakoff, D. Sirot, C. Chanal, and J. Sirot. 2001. New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates. Antimicrob. Agents Chemother. 45:1278-1280.
4. De Meester, F., B. Joris, G. Reckinger, C. Bellefroid-Bourguignon, J.-M. Frère, and S. G. Waley. 1987. Automated analysis of enzyme inactivation phenomena. Application to β-lactamases and dd-peptidases. Biochem. Pharmacol. 36:2393-2403.
5. Inouye, S., X. Soberon, T. Franceschini, K. Nakamura, K. Itakura, and M. Inouye. 1982. Role of positive charge on the amino-terminal region of the signal peptide in protein secretion across the membrane. Proc. Natl. Acad. Sci. USA 79:3438-3441.
6. Jacoby, G. A. 1997. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect. Dis. Clin. N. Am. 11:875-887.
7. Matagne, A., J. Lamotte-Brasseur, G. Dive, J. R. Knox, and J. M. Frere. 1993. Interactions between active-site-serine β-lactamases and compounds bearing a methoxy side chain on the alpha-face of the β-lactam ring: Kinetic and molecular modelling studies. Biochem. J. 293:607-611.
8. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. NCCLS document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Pagani, L., M. Perilli, R. Migliavacca, F. Luzzaro, and G. Amicosante. 2000. Extended-spectrum TEM- and SHV-type β-lactamase-producing Klebsiella pneumoniae strains causing outbreaks in intensive care units in Italy. Eur. J. Clin. Microbiol. Infect. Dis. 19:765-772.
10. Pai, H., S. Lyu, J. H. Lee, Y. Kwon, J. W. Kim, and K. W. Choe. 1999. Survey of extended-spectrum-β-lactamases in clinical isolates of E. coli and K. pneumoniae: Prevalence of TEM-52 in Korea. J. Clin. Microbiol. 37:1758-1763.
11. Perilli, M., A. Felici, N. Franceschini, A. De Santis, L. Pagani, F. Luzzaro, A. Oratore, G. M. Rossolini, J. R. Knox, and G. Amicosante. 1997. Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain. Antimicrob. Agents Chemother. 41:2374-2382.
12. Perilli, M., E. Dell'Amico, B. Segatore, M. R. De Massis, C. Bianchi, F. Luzzaro, G. M. Rossolini, A. Toniolo, G. Nicoletti, and G. Amicosante. 2002. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40:611-614.
13. Perilli, M., B. Segatore, M. R. De Massis, N. Franceschini, C. Bianchi, G. M. Rossolini, and G. Amicosante. 2002. Characterization of a new extended-spectrum β-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey. Antimicrob. Agents Chemother. 46:925-928.
14. Poyart, C., P. Mugnier, G. Quesne, P. Berche, and P. Trieu-Cuot. 1998. A novel extended-spectrum TEM-type β-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in K pneumoniae. Antimicrob. Agents Chemother. 42:108-113.
15. Raquet, X., J. Lamotte-Brasseur, E. Fonzè, S. Goussard, P. Courvalin, and J. M. Frère. 1994. TEM β-lactamase mutants hydrolysing third-generation cephalosporins. J. Mol. Biol. 244:625-639.
16. Sideraki, V., W. Huang, T. Palzkill, and H. F. Gilbert. 2001. A secondary drug-resistance mutation of TEM-1 β-lactamase that suppresses misfolding and aggregation. Proc. Natl. Acad. Sci. USA 98:283-288.